Catalyst Pharmaceutical
CPRX
CPRX
367 hedge funds and large institutions have $2.39B invested in Catalyst Pharmaceutical in 2025 Q1 according to their latest regulatory filings, with 73 funds opening new positions, 126 increasing their positions, 122 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
367
Holders Change
+33
Holders Change %
+9.88%
% of All Funds
4.99%
Holding in Top 10
6
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+100%
% of All Funds
0.08%
New
73
Increased
126
Reduced
122
Closed
32
Calls
$2.48M
Puts
$547K
Net Calls
+$1.93M
Net Calls Change
+$1.69M
Top Buyers
| 1 |
Fundsmith LLP
London,
United Kingdom
|
+$52.2M |
| 2 |
MIM
MetLife Investment Management
Whippany,
New Jersey
|
+$15.9M |
| 3 |
Swedbank
Stockholm,
Sweden
|
+$14.9M |
| 4 |
Allianz Asset Management
Munich,
Germany
|
+$13.5M |
| 5 |
NVCHI
New Vernon Capital Holdings II
Morristown,
New Jersey
|
+$13.3M |
Top Sellers
| 1 |
Pacer Advisors
Malvern,
Pennsylvania
|
-$51M |
| 2 |
First Trust Advisors
Wheaton,
Illinois
|
-$48.3M |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
-$20M |
| 4 |
BlackRock
New York
|
-$15.1M |
| 5 |
Voloridge Investment Management
Jupiter,
Florida
|
-$10.2M |